This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.
This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. Legal access does not necessarily equate to financial access. Although there is growing access to cannabis medicines, there is an increasing need for credible research and educational platforms.
Legislation that would have significantly expanded patient access to medical cannabis in Rhode Island was held in a senate committee for further study, ultimately killing the bill. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.
Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022.
Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. In 2019, Georgia’s General Assembly passed Georgia’s Hope Act, which legalized the regulated cultivation of marijuana in the State.
The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Some of the qualifying health conditions include epilepsy, neuropathic pain, chemotherapy side effects, a need for palliative care, and pain linked to multiple sclerosis, according to France24.
“In its first year of operation, Pennsylvania’s medical marijuana program helped 83,000 folks access medication, dispensed from nearly 600,000 times at approved dispensaries across the state,” Sen. — Senator Jay Costa (@Senatorcosta) February 15, 2019. Costa wrote on Twitter.
These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s.
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data.
Texas’ consistent gains can, in large part, be attributed to its recent efforts to increase access to its program. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.
The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.
As of 2019, the population in the state of Texas was estimated to be around 29 million and is rapidly growing as we speak. It allowed for low THC cannabis products for patients in Texas that had intractable epilepsy. In 2019 the law was updated thanks to HB 3703. Texas is known for doing it big.
In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% Patients do not need to register with the state or pay a fee to access the medical cannabis program. THC under the Texas Compassionate Use Ac t. Shutterstock).
Louisiana’s medical marijuana program may have been established three years ago, but patients were not granted access to medicine until August of 2019 when the first round of the product became available. Home cultivation remains illegal for the more than 4,000 registered medical marijuana patients. House Bill 418.
The four approvals mark the first expansion of the list of conditions that can be treated with medical cannabis since 2019. IDPH looks forward to working with our medical providers to ensure appropriate access for individuals struggling with these newly approved conditions. Those four newly added conditions bring the total to 56.
Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. Even after being prescribed epilepsy medication, her condition continued to deteriorate. “No Mothers Push for Cannabis Access in Indonesia.
On Monday, March 18, 2019, Gov. After two years of waiting, the patients of Florida have finally been granted access to smokeable forms of medical cannabis, but they still cannot go out and purchase it right away. DeSantis signed Senate Bill 182 “Medical Use of Marijuana” into law.
Cannabis is easily accessible, and the regulations are loosening up quite a bit. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy. It proposes that cannabis can strictly be accessed by prescription alone. .
While Oregon became the first state to decriminalize all drugs , this election cycle also saw five other states passing legislation that will ultimately make cannabis more accessible to their citizens.
It was during a public hearing on Saturday, July 24, 2021, that the Georgia Access to Medical Cannabis Commission (GMCC) awarded two Class 1 licenses and four Class 2 licenses to produce low-THC medical cannabis oil. However, patient access to low-THC oil was expanded on May 9, 2018, when Deal inked his signature on SB 16.
Back in 2019 the country had its first CBD vending machine and had approved more than two dozen licenses for cannabis cultivation and processing. Would-be medical cannabis patients can gain access if they receive a prescription from a presiding physician. What Greek law permits for medical patients? Is CBD legal in Greece?
In-state cultivation and distribution weren’t legalized until 2019. But the law required the medical program to be overseen by a governor-appointed board and there was no legal access to cannabis, so no patients were ever served. The only way to access the plant and its products is through the legacy market (aka the black market).
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.
Experts say significant barriers to legal access have produced a failed system and are calling for an independent regulator. Broadcast: Fri 22 Feb 2019, 5:10pm. Featured: Michael Lambert, father of child with epilepsy. Carol Ireland, managing director, Epilepsy Action Australia. Duration: 3min 52sec. More Information.
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Shutterstock). It’s everywhere. An anti-seizure wonder drug.
30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019. Google Translation. Sick group 1. Source: [link].
The first day that Ohio medical cannabis patients were granted safe, reliable access to lab-tested medication via dispensaries, they collectively spent more than $75,0000 on nearly nine pounds of flower. Epilepsy or another seizure disorder. Only four retail locations were open for business on the first day that sales began.
Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. Millions of individuals are reporting CBD having aided in helping them with: Anxiety.
Unfortunately, this was blocked by the Senate in 2019 when Duterte changed his tune and declared the opposite in a campaign rally in Negros Occidental. This probably inspired the approval on the third and final reading of House Bill (HB) No. 6517 (Philippine Compassionate Medical Cannabis Act).
T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. September 23, 2019. What do experts say?
To some extent, cannabis has already been decriminalized for personal use in Israel since 2019, when a law went into effect that reduced the penalties for small-scale possession to a simple fine instead of criminal charges. Can foreigners access medical marijuana?
For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. CANNABIS PRIMER. Glossary of Marijuana Terminologyvia CannaInsider.com. Americans for Safe Access.org.
In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. Along with Sativex, the cannabis-based medicine Epidylolex is approved for use with specific conditions like severe forms of pediatric epilepsy and can be prescribed by a physician.
In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition. Source: [link].
Anvisa approved the regulation of cannabis-based products in December 2019 and until now it had only authorized the use of three other medicines with this active principle in the country.
In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. Along with Sativex, the cannabis-based medicine Epidylolex is approved for use with specific conditions like severe forms of pediatric epilepsy and can be prescribed by a physician.
The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.
Until 2019, however, no law provided a way to access that oil. With the passage of HB 324 and the creation of the Georgia Access to Medical Cannabis Commission in 2019, Georgia seemed poised to begin licensing producers and dispensaries. total THC to treat intractable seizures or epilepsy in certain circumstances.
This allowed NY residents who needed MMJ to access it safely, within limitations. It was officially decriminalized in 2019 , and as of March 2021, has become legal for adult recreational use as well as medical use. This guarantees you access to the wide variety of MMJ products available for sale at the state’s dispensaries.
Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. As more patients have sought out legal medical cannabis patient status in the country, it is believed that the number of registered U.K.
Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.
The MDA published proposed rules, which it recently amended , to align with the USDA hemp interim rules published on October 31, 2019. Since 2014, access to hemp extracts has been limited to patients suffering from intractable epilepsy that are registered with the Missouri Department of Health.
In April 2019, House Bill 324 was approved, enabling in-state cultivation and the sale of low-THC oil. The medical conditions that qualify for this program typically include severe and debilitating conditions like epilepsy, cancer, multiple sclerosis, and Parkinson’s disease, among others.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content